Canaccord Genuity Maintains a 'Buy' on Bill Barrett (NYSE: BBG); Better Late Than Never: Cuts Gas Capex, Raises oil Allocation
Tweet
Share
E-mailGet Alerts BBG Hot Sheet
Price: $4.84 --0%
Rating Summary:
5 Buy, 15 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
5 Buy, 15 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity maintains a 'Buy' on Bill Barrett (NYSE: BBG) price target lowered $1 to $41.
Analyst, John Gerdes, said, "We are reducing our price target ue to lower overall capital spending largely offset by a higher allocation toward oil activity. We believe Barrett’s CFPS should decline this year as hedges roll off and then grow 11% annually through ’16 as oil growth ramps. Catalysts include asset divestitures, oil exploration and additional refinery commitments."
For an analyst ratings summary and ratings history on Bill Barrett click here. For more ratings news on Bill Barrett click here.
Shares of Bill Barrett closed at $29.86 yesterday.
Analyst, John Gerdes, said, "We are reducing our price target ue to lower overall capital spending largely offset by a higher allocation toward oil activity. We believe Barrett’s CFPS should decline this year as hedges roll off and then grow 11% annually through ’16 as oil growth ramps. Catalysts include asset divestitures, oil exploration and additional refinery commitments."
For an analyst ratings summary and ratings history on Bill Barrett click here. For more ratings news on Bill Barrett click here.
Shares of Bill Barrett closed at $29.86 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Viking Holdings (VIK) PT Raised to $82 at Mizuho
- Deere (DE) PT Lowered to $728 at UBS as Agricultural Machinery Cycle Gets Closer
- Netease Inc. (9999:HK) (NTES) PT Lowered to HK$226 at Macquarie
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
